Alveolar Hemorrhage: A Rare Complication of Eptifibatide (Glycoprotein IIb/IIIa Inhibitor)

Mohsen  Sadeghi Ghahrodi; Yadallah  Mahmoody; Hadi  Sheikhlou; Hossein  Aalaei Andabili

International Cardiovascular Research Journal

The Official Annually Journal of Cardiovascular Research Center, Shiraz University of Medical Sciences

Current Issue All Issues In Press Accepted Manuscripts Search

Journal Information Boards & Committees Indexing and Listing Sources Journal Metrics Publication Ethics and Publication Malpractice Statement Contact Us Support Reviewer and AE Registration Form

APC

Authors Guide Submit Manuscript

Alveolar Hemorrhage: A Rare Complication of Eptifibatide (Glycoprotein IIb/IIIa Inhibitor)

Author(s):

Mohsen Sadeghi Ghahrodi¹,

Yadallah Mahmoody^1,*,

Hadi Sheikhlou¹,

Hossein Aalaei Andabili¹

1Cardiovascular Research Center, Medical Science of Bagheiatallah University, Bagheiatallah Hospital, Tehran, Iran

International Cardiovascular Research Journal:Vol. 5, issue 4; e11219

Published online:Dec 31, 2011

Article type:Case Report

Received:Feb 27, 2017

Accepted:May 26, 2011

How to Cite:Mohsen Sadeghi GhahrodiYadallah MahmoodyHadi SheikhlouHossein Aalaei AndabiliAlveolar Hemorrhage: A Rare Complication of Eptifibatide (Glycoprotein IIb/IIIa Inhibitor).Int Cardiovasc Res J.5(4):e11219.

Abstract

A 67-year-old man presented with symptoms of typical chest pain. An electrocardiogram (EKG) showed ST elevation at the inferior leads and ST depression at the anterior leads. His blood pressure was 80/50 mmHg with a pulse rate of 100 beats/min. The glycoprotein IIb/IIIa inhibitor (eptifibatide) was administrated and a primary percutaneous coronary intervention PCI was done. Despite the restoration of TIMI grade 3/3 flow, the patient’s blood pressure dropped and pulmonary edema occurred. On the second day following PCI, the hemoglobin level started to drop. While working up the case, the patient suddenly complained of dyspnea and had a bloody foamy discharge from his mouth. Due to severe hypoxemia orotracheal intubation was carried out. A chest x-ray revealed an alveolar hemorrhage. Treatment with high dose hydrocortisone was started and the patient went on mechanical ventilation for seven days. Following extubation, the patient was put under close observation for five days and then discharged from hospital without any complications. During a 3 month follow-up, he has remained symptom free.

Keywords

Hemorrhage

Eptifibatide

Glycoproteins

Fulltext

The full text is available in PDF.

References

1.
The references are available in PDF.

comments